MicroRNA expression is differentially altered by xenobiotic drugs in different human cell lines


Autoria(s): RODRIGUES, Alice C.; LI, Xin; RADECKI, Laura; PAN, Yu-Zhuo; WINTER, Jerrold C.; HUANG, Min; YU, Ai-Ming
Contribuinte(s)

UNIVERSIDADE DE SÃO PAULO

Data(s)

20/10/2012

20/10/2012

2011

Resumo

Several noncoding microRNAs (miR or miRNA) have been shown to regulate the expression of drug-metabolizing enzymes and transporters. Xenobiotic drug-induced changes in enzyme and transporter expression may be associated with the alteration of miRNA expression. Therefore, this study investigated the impact of 19 xenobiotic drugs (e. g. dexamethasone, vinblastine, bilobalide and cocaine) on the expression of ten miRNAs (miR-18a, -27a, -27b, -124a, -148a, -324-3p, -328, -451, -519c and -1291) in MCF-7, Caco-2, SH-SY5Y and BE(2)-M17 cell systems. The data revealed that miRNAs were differentially expressed in human cell lines and the change in miRNA expression was dependent on the drug, as well as the type of cells investigated. Notably, treatment with bilobalide led to a 10-fold increase of miR-27a and a 2-fold decrease of miR-148a in Caco-2 cells, but no change of miR-27a and a 2-fold increase of miR-148a in MCF-7 cells. Neuronal miR-124a was generally down-regulated by psychoactive drugs (e. g. cocaine, methadone and fluoxetine) in BE(2)-M17 and SH-SY5Y cells. Dexamethasone and vinblastine, inducers of drug-metabolizing enzymes and transporters, suppressed the expression of miR-27b, -148a and -451 that down-regulate the enzymes and transporters. These findings should provide increased understanding of the altered gene expression underlying drug disposition, multidrug resistance, drug-drug interactions and neuroplasticity. Copyright (C) 2011 John Wiley & Sons, Ltd.

University at Buffalo

University at Buffalo

State University of New York

State University of New York

National Institutes of Health (NIH)[R01DA021172]

U.S. National Institutes of Health (NIH)

Pesquisa do Estado de Sao Paulo (FAPESP), Sao Paulo, Brazil[2008/014065-9]

Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)

Identificador

BIOPHARMACEUTICS & DRUG DISPOSITION, v.32, n.6, p.355-367, 2011

0142-2782

http://producao.usp.br/handle/BDPI/28684

10.1002/bdd.764

http://dx.doi.org/10.1002/bdd.764

Idioma(s)

eng

Publicador

WILEY-BLACKWELL

Relação

Biopharmaceutics & Drug Disposition

Direitos

restrictedAccess

Copyright WILEY-BLACKWELL

Palavras-Chave #miRNA #drug disposition #metabolism #regulation #xenobiotic #BREAST-CANCER CELLS #NUCLEAR RECEPTOR #GINKGO-BILOBA #5-METHOXY-N,N-DIMETHYLTRYPTAMINE METABOLISM #HUMAN NEUROBLASTOMA #ABCG2 EXPRESSION #CARCINOMA-CELLS #UP-REGULATION #PROTEIN #RNA #Pharmacology & Pharmacy
Tipo

article

original article

publishedVersion